Metformin reduces radiation-induced cardiac toxicity risk in patients having breast cancer.
Year: 2019
Type: article
Study design: Observational Study
Abstract: = 0.589). Our results suggest that metformin use during adjuvant breast RT was associated with reduced RICT risk in women with early-stage breast cancer.
Source: PubMed
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2980808845
